William McDonald, MD
Orthopaedic Surgery · Batesville, INNPI 1144286774
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Johnson & Johnson at 34.6% of the total. Reporting peaked in 2024 at $265 and has fallen 69.8% since, to $80 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in IN, where the typical reported total is $4,533.
Across 35 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$231
- Ferring Pharmaceuticals Inc.$103
- Zimmer Biomet$79
- DJO, LLC$56
- Blue Surgical LLC$46
- Davol Inc.$46
- plus $107 from 5 others
What the payments were for
- Food & beverage$667100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $231 |
| Ferring Pharmaceuticals Inc. | 6 | $103 |
| Zimmer Biomet | 5 | $79 |
| DJO, LLC | 3 | $56 |
| Blue Surgical LLC | 2 | $46 |
| Davol Inc. | 2 | $46 |
| AbbVie(2 entities) | 2 | $34 |
| Heraeus Medical, LLC. | 2 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Endo USA, Inc. | 1 | $14 |
| Baudax Bio Inc. | 1 | $13 |
How this compares
$667 in reported general payments places this provider in the 20th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 25 | $158 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $125 |
| Diclofenac Sodium | 17 | $109 |
| Clindamycin Hcl | 11 | $52 |
| Tramadol Hcl | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Batesville
- Frank KolisekGreenwood$7.5M
- David FisherIndianapolis$5.9M
- Michael BerendIndianapolis$4M
- John WilliamsFort Wayne$2.7M
- Sanford KunkelIndianapolis$1.9M
- Hill HastingsIndianapolis$1.6M
- Mark KlaassenElkhart$1.3M
- Alan McGeeFort Wayne$1.1M
- Lindsey RolstonNew Castle$1.1M
- John MedingMooresville$998K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.